Experimental and Clinical Research Center (ECRC)

ECRC

As a joint institution of the Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, the Experimental and Clinical Research Center (ECRC) provides the scientific and technical infrastructure, expertise and resources for translational research, including clinical trials, according to competitive criteria. The ECRC provides access to highly advanced technologies, such as ultra high field magnetic resonance imaging, and has a cleanroom laboratory for the production of immunotherapeutic vaccines and a unique infrastructure for patient-centered research in the form of a clinical pharmacology unit in accordance with the American “clinical research center” model. Studies with outpatients can be carried out in specialized university outpatient clinics. If a clinical trial requires hospitalization of the trial participant for several days, this can be provided in the inpatient hospital sites of the Charité.
The aim is to transform findings from basic research into clinical practice to improve the diagnosis, prevention and treatment of the most prevalent diseases in our society (cardiovascular and metabolic diseases, cancer, neurological disorders). An important aspect of the ECRC strategy is to facilitate extensive collaboration and communication between basic scientists and clinical researchers, thus creating a common platform as the basis for successful cooperation.

www.mdc-berlin.de/ecrc

News research

Inhibitor of lipid kinase PI3KC2α identified as potential new treatment of thrombosis

The lipid kinase PI3KC2α is a potential pharmacological target for the treatment of thrombosis and, possibly, cancer. Researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)...

more ...

Dense and permeable: molecular organization of tight junctions decoded

They seal epithelial cells and, under certain conditions, allow the passage of ions and water: Tight junctions form a paracellular barrier in tissues and their dysfunction is associated with diseases ...

more ...

Million euro support for MyoPax

MyoPax, a new spin-off of the Max Delbrück Center and Charité, receives a 1.3 million euros loan to jump-start its entrepreneurial activities. The start-up develops regenerative therapies for previous...

more ...

Events Campus

04.10.2022, 16:00
Auf der Suche nach der Gesundheit - Wie Forschung funktioniert

Vorlesungsreihe: Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch

more ...

06.10.2022, 09:00
Bioinformatik im Labor 4.0

Eine eintägige Einführung für Technische Angestellte und Laborant*innen in die aktuelle Bioinformatik und in das Next Generation Sequencing (NGS) mit praktischen Übungen zum Umgang mit Biodatenbanken.

more ...

07.11.2022, 09:00
Fachkraft für Molekularbiologie (TÜV)

Das 11-tägige Seminar vermittelt Grundlagen der wichtigsten Labormethoden der modernen Molekularbiologie und Einblicke in die klinische Forschung

more ...

Sponsoren der Website: